신종 코로나 바이러스에 관한 IPOPI 국제본부에서 보내온 소식과 정보(수신 : PID Korea가족)
Coronaviruses are common in many different animal species and it is rare that they infect people and spread between them, but it happens. During previous coronavirus outbreaks, the person-to-person transmission occurred through droplets, contact and fomites, which suggests that the transmission mode of the 2019- nCoV can be similar. There is currently no vaccine available.
A respiratory virus that can be spread from person-to-person is a risk for PID patients. Therefore, PID patients should be cautious and keep track of developments of the virus in their region. Whilst immunoglobulin replacement therapy provides protection against a range of infections, it does not guarantee immunity against coronavirus. The World Health Organization’s and the Centers for Disease Control and Prevention’s recommendations to reduce exposure to and transmission of the coronavirus 2019-nCoV include but are not limited to:
- Avoid close contact with people suffering from acute respiratory infections
Avoid close contact with anyone who has fever and cough
- People with symptoms of acute respiratory infection should practice cough etiquette (maintain distance, cover coughs and sneezes with disposable tissues or clothing, and wash hands) and wear a respiratory mask
Frequent handwashing by using alcohol-based hand rub or soap and water, especially after direct contact with ill people or their environment
PID patients in endemic areas
For PID patients who live in endemic areas, beyond the precautions mentioned above, we advise prompt contact with a doctor if an infection is suspected. Patients should always keep the details of their PID diagnosis and medical charts, medications, PID expert doctor and next of kin at hand, in case urgent medical care is needed. We further recommend continuous monitoring of information from national public health authorities, statements from regional centres for disease prevention and control as well as from the World Health Organization.
IPOPI is monitoring the situation and following developments closely and will continue to update our members if necessary.
Please find the full statement in attachment and don’t hesitate to reach out with any questions you might have.
NMO Programmes Officer
IPOPI - International Patient Organisation for Primary Immunodeficiencies
Av. Aida, Bloco 8, Escritório 821
2765-187 Estoril, Portugal
Tel/Fax: +351 21 407 5720
IPOPI is a charity registered in the UK - Charity No 1058005
Rocky Bottom, Trerieve
Downderry, Cornwall PL11 3LY, UK
Tel/Fax: +44 1503 250 668
All outgoing e-mails are checked by Kaspersky Anti-virus.
This e-mail contains information which is confidential, legally privileged and protected by law and intended solely for the intended recipient.
Interception is illegal. Reasonable steps have been taken to ensure the accuracy and integrity of our communications, but we do not accept liability for any unauthorised e-mail or the unauthorised transmission of material by e-mail. If you are not the intended recipient you may not peruse, use, distribute or copy this message or any attached file. Any such use is prohibited and may be unlawful. Please notify us by return e-mail and delete the original. Views and opinions expressed in this e-mail are those of the sender unless clearly stated to be that of IPOPI